<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A patient with M2-ANLL and a 46,XX,del(5)(q22q33), t(2;11)(p21;q24) karyotype is described </plain></SENT>
<SENT sid="1" pm="."><plain>The diagnosis was made after a short period of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>After chemotherapy consisting of <z:chebi fb="0" ids="41977">Daunorubicin</z:chebi> and Arabinosylcytosine in continuous infusion, the patient reached a complete remission </plain></SENT>
<SENT sid="3" pm="."><plain>The chromosome pattern described here has been observed in two other patients with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> and <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>The breakpoints on the chromosomes 2, 5 and 11 allow us to hypothesize the involvement of N-myc, c-fms, GM-CSF and IL-3 genes </plain></SENT>
</text></document>